Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 2068-2071, April 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shipley, G. D.
Right arrow Articles by Moses, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shipley, G. D.
Right arrow Articles by Moses, H. L.

Reversible Inhibition of Normal Human Prokeratinocyte Proliferation by Type ß Transforming Growth Factor-Growth Inhibitor in Serum-free Medium1

Gary D. Shipley, Mark R. Pittelkow, John J. Wille, Jr., Robert E. Scott and Harold L. Moses2

Departments of Cell Biology [G. D. S., R. J. W., R. E. S., H. L. M.], Dermatology [M. R. P.], and Pathology [R. E. S., H. L. M.], Mayo Clinic/Foundation, Rochester, Minnesota 55905

Type ß transforming growth factor-growth inhibitor (TGFß/GI) causes normal human prokeratinocytes to arrest growth predominantly in the G1 phase of the cell cycle within 48 h after log phase cultures are exposed to the factor in serum-free medium. The growth arrest induced by TGFß/GI is reversible because the cells from treated cultures can be replated into fresh medium and grown into large colonies. Normal prokeratinocytes are demonstrated to secrete TGFß/GI-like molecules into the culture medium and to have specific cell surface receptors for this molecule. In contrast, a human squamous cell carcinoma, SCC-25, does not arrest growth when exposed to TGFß/GI. These cells, unlike the normal prokeratinocytes, do not exhibit detectable cell surface receptors for the factor.

1 This work was supported by NIH CA16816 and NIH CA27217 to H. L. M., NIH CA39911 to G. D. S., NIH CA28240 to R. E. S., and the Mayo Foundation.

2 To whom requests for reprints should be addressed, at Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, TN 37232.

Received 6/18/85. Revised 12/ 3/85. Accepted 1/ 2/86.




This article has been cited by other articles:


Home page
Acta Biochim Biophys SinHome page
H. Fu, Z. Hu, J. Wen, K. Wang, and Y. Liu
TGF-{beta} promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways
Acta Biochim Biophys Sin, August 1, 2009; 41(8): 648 - 656.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
T. Higashi, S. Kyo, M. Inoue, H. Tanii, and K. Saijoh
Novel Functional Single Nucleotide Polymorphisms in the Latent Transforming Growth Factor-{beta} Binding Protein-1L Promoter: Effect on Latent Transforming Growth Factor-{beta} Binding Protein-1L Expression Level and Possible Prognostic Significance in Ovarian Cancer
J. Mol. Diagn., July 1, 2006; 8(3): 342 - 350.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Natarajan, J. D. Omobono II, Z. Guo, S. Hopkinson, A. J.F. Lazar, T. Brenn, J. C. Jones, and J. G. Rheinwald
A Keratinocyte Hypermotility/Growth-Arrest Response Involving Laminin 5 and p16INK4A Activated in Wound Healing and Senescence
Am. J. Pathol., June 1, 2006; 168(6): 1821 - 1837.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
M. Nair, A. Teng, V. Bilanchone, A. Agrawal, B. Li, and X. Dai
Ovol1 regulates the growth arrest of embryonic epidermal progenitor cells and represses c-myc transcription
J. Cell Biol., April 24, 2006; 173(2): 253 - 264.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Sakaguchi, H. Sonegawa, T. Nukui, Y. Sakaguchi, M. Miyazaki, M. Namba, and N.-h. Huh
Bifurcated converging pathways for high Ca2+- and TGF{beta}-induced inhibition of growth of normal human keratinocytes
PNAS, September 27, 2005; 102(39): 13921 - 13926.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Krampert, S. Kuenzle, S. N.-M. Thai, N. Lee, M. L. Iruela-Arispe, and S. Werner
ADAMTS1 Proteinase Is Up-regulated in Wounded Skin and Regulates Migration of Fibroblasts and Endothelial Cells
J. Biol. Chem., June 24, 2005; 280(25): 23844 - 23852.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. Mazzieri, V. Jurukovski, H. Obata, J. Sung, A. Platt, E. Annes, N. Karaman-Jurukovska, P.-E. Gleizes, and D. B. Rifkin
Expression of truncated latent TGF-{beta}-binding protein modulates TGF-{beta} signaling
J. Cell Sci., May 15, 2005; 118(10): 2177 - 2187.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Chaturvedi and D. K. Sarkar
Involvement of Protein Kinase C-Dependent Mitogen-Activated Protein Kinase p44/42 Signaling Pathway for Cross-Talk between Estradiol and Transforming Growth Factor-{beta}3 in Increasing Basic Fibroblast Growth Factor in Folliculostellate Cells
Endocrinology, February 1, 2004; 145(2): 706 - 715.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
M. Sakaguchi, M. Miyazaki, M. Takaishi, Y. Sakaguchi, E. Makino, N. Kataoka, H. Yamada, M. Namba, and N.-h. Huh
S100C/A11 is a key mediator of Ca2+-induced growth inhibition of human epidermal keratinocytes
J. Cell Biol., November 24, 2003; 163(4): 825 - 835.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. O. Fortunel, J. A. Hatzfeld, P.-A. Rosemary, C. Ferraris, M.-N. Monier, V. Haydont, J. Longuet, B. Brethon, B. Lim, I. Castiel, et al.
Long-term expansion of human functional epidermal precursor cells: promotion of extensive amplification by low TGF-{beta}1 concentrations
J. Cell Sci., October 1, 2003; 116(19): 4043 - 4052.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. M. Owens, M. R. Romero, C. Gardner, and F. M. Watt
Suprabasal {alpha}6{beta}4 integrin expression in epidermis results in enhanced tumourigenesis and disruption of TGF{beta} signalling
J. Cell Sci., September 15, 2003; 116(18): 3783 - 3791.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Gurlek, M. R. Pittelkow, and R. Kumar
Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation
Endocr. Rev., December 1, 2002; 23(6): 763 - 786.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
Q H Song, V E Klepeis, M A Nugent, and V Trinkaus-Randall
TGF-{beta}1 regulates TGF-{beta}1 and FGF-2 mRNA expression during fibroblast wound healing
Mol. Pathol., June 1, 2002; 55(3): 164 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Dennler, M.-J. Goumans, and P. ten Dijke
Transforming growth factor {beta} signal transduction
J. Leukoc. Biol., May 1, 2002; 71(5): 731 - 740.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Yang, T. Chan, J. Demare, T. Iwashina, A. Ghahary, P. G. Scott, and E. E. Tredget
Healing of Burn Wounds in Transgenic Mice Overexpressing Transforming Growth Factor-{beta}1 in the Epidermis
Am. J. Pathol., December 1, 2001; 159(6): 2147 - 2157.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Tsushima, N. Ito, S. Tamura, Y. Matsuda, M. Inada, I. Yabuuchi, Y. Imai, R. Nagashima, H. Misawa, H. Takeda, et al.
Circulating Transforming Growth Factor {beta}1 as a Predictor of Liver Metastasis after Resection in Colorectal Cancer
Clin. Cancer Res., May 1, 2001; 7(5): 1258 - 1262.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. Hentges, M. Pastorcic, A. De, N. Boyadjieva, and D. K. Sarkar
Opposing Actions of Two Transforming Growth Factor-{beta} Isoforms on Pituitary Lactotropic Cell Proliferation
Endocrinology, April 1, 2000; 141(4): 1528 - 1535.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. McNeil, S. A. Hobson, V. Nipper, and K. D. Rodland
Functional Calcium-sensing Receptors in Rat Fibroblasts Are Required for Activation of SRC Kinase and Mitogen-activated Protein Kinase in Response to Extracellular Calcium
J. Biol. Chem., January 9, 1998; 273(2): 1114 - 1120.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Sun and C. Chen
Expression of Transforming Growth Factor beta  Type III Receptor Suppresses Tumorigenicity of Human Breast Cancer MDA-MB-231 Cells
J. Biol. Chem., October 3, 1997; 272(40): 25367 - 25372.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Saeki, A. Yuo, M. Kato, K. Miyazono, Y. Yazaki, and F. Takaku
Cell Density-dependent Apoptosis in HL-60 Cells, Which Is Mediated by an Unknown Soluble Factor, Is Inhibited By Transforming Growth Factor beta 1 and Overexpression of Bcl-2
J. Biol. Chem., August 8, 1997; 272(32): 20003 - 20010.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Martinez-Esparza, C. Jimenez-Cervantes, F. Beermann, P. Aparicio, J. A. Lozano, and J. C. Garcia-Borron
Transforming Growth Factor-beta 1 Inhibits Basal Melanogenesis in B16/F10 Mouse Melanoma Cells by Increasing the Rate of Degradation of Tyrosinase and Tyrosinase-related Protein-1
J. Biol. Chem., February 14, 1997; 272(7): 3967 - 3972.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Frank, M. Madlener, and S. Werner
Transforming Growth Factors beta1, beta2, and beta3 and Their Receptors Are Differentially Regulated during Normal and Impaired Wound Healing
J. Biol. Chem., April 26, 1996; 271(17): 10188 - 10193.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. F. Sachsenmeier, N. Sheibani, S. J. Schlosser, and B. L. Allen-Hoffmann
Transforming Growth Factor-beta1 Inhibits Nucleosomal Fragmentation in Human Keratinocytes following Loss of Adhesion
J. Biol. Chem., January 5, 1996; 271(1): 5 - 8.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Kato, A. Ishizaki, U. Hellman, C. Wernstedt, M. Kyogoku, K. Miyazono, C.-H. Heldin, and K. Funa
A Human Keratinocyte Cell Line Produces Two Autocrine Growth Inhibitors, Transforming Growth Factor-[IMAGE] and Insulin-like Growth Factor Binding Protein-6, in a Calcium- and Cell Density-dependent Manner
J. Biol. Chem., May 26, 1995; 270(21): 12373 - 12379.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Frank, G. Hübner, G. Breier, M. T. Longaker, D. G. Greenhalgh, and S. Werner
Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes
J. Biol. Chem., May 26, 1995; 270(21): 12607 - 12613.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
W Cui, D J Fowlis, F M Cousins, E Duffie, S Bryson, A Balmain, and R J Akhurst
Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice.
Genes & Dev., April 15, 1995; 9(8): 945 - 955.
[Abstract] [PDF]


Home page
Genes Dev.Home page
A B Glick, M M Lee, N Darwiche, A B Kulkarni, S Karlsson, and S H Yuspa
Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.
Genes & Dev., October 15, 1994; 8(20): 2429 - 2440.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
F van Ruissen, P. van Erp, G. de Jongh, J. Boezeman, P. van de Kerkhof, and J Schalkwijk
Cell kinetic characterization of growth arrest in cultured human keratinocytes
J. Cell Sci., January 8, 1994; 107(8): 2219 - 2228.
[Abstract] [PDF]


Home page
CROBMHome page
C. P. Kiritsy and S. E. Lynch
Role of Growth Factors in Cutaneous Wound Healing: A Review
Critical Reviews in Oral Biology & Medicine, January 1, 1993; 4(5): 729 - 760.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
C.S. Murphy, J.A. Pietenpol, K. Munger, P.M. Howley, and H.L. Moses
c-myc and pRB: Role in TGF-{beta}1 Inhibition of Keratinocyte Proliferation
Cold Spring Harb Symp Quant Biol, January 1, 1991; 56(0): 129 - 135.
[Abstract] [PDF]


Home page
Genes Dev.Home page
P D Rathjen, J Nichols, S Toth, D R Edwards, J K Heath, and A G Smith
Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations.
Genes & Dev., December 1, 1990; 4(12b): 2308 - 2318.
[Abstract] [PDF]


Home page
Genes Dev.Home page
K M Lyons, R W Pelton, and B L Hogan
Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development.
Genes & Dev., November 1, 1989; 3(11): 1657 - 1668.
[Abstract] [PDF]


Home page
ScienceHome page
J. Elder, G. Fisher, P. Lindquist, G. Bennett, M. Pittelkow, R. Coffey Jr, L Ellingsworth, R Derynck, and J. Voorhees
Overexpression of transforming growth factor alpha in psoriatic epidermis
Science, February 10, 1989; 243(4892): 811 - 814.
[Abstract] [PDF]


Home page
Arch DermatolHome page
G. D. Shipley and M. R. Pittelkow
Control of Growth and Differentiation In Vitro of Human Keratinocytes Cultured in Serum-free Medium
Arch Dermatol, November 1, 1987; 123(11): 1541a - 1544a.
[Abstract] [PDF]


Home page
ScienceHome page
G. Silberstein and C. Daniel
Reversible inhibition of mammary gland growth by transforming growth factor-beta
Science, July 17, 1987; 237(4812): 291 - 293.
[Abstract] [PDF]


Home page
ScienceHome page
M. Sporn, A. Roberts, L. Wakefield, and R. Assoian
Transforming growth factor-beta: biological function and chemical structure
Science, August 1, 1986; 233(4763): 532 - 534.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.